BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang L, Xu J, Ni J, Gao X, Zhu Z, Dong D, Wang X, Shi C, Tao X, Dong W, Gao Y. A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population. DNA Cell Biol 2012;31:1480-5. [PMID: 22731821 DOI: 10.1089/dna.2012.1706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Xu C, Zhou W, Wang Y, Qiao L. Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett. 2014;345:216-222. [PMID: 23981576 DOI: 10.1016/j.canlet.2013.08.035] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
2 Wei Z, Shen Y, Zhou C, Cao Y, Deng H, Shen Z. CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma. Bioengineered 2022;13:13784-800. [PMID: 35712757 DOI: 10.1080/21655979.2022.2084254] [Reference Citation Analysis]
3 Kent A, Longino NV, Christians A, Davila E. Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy. Front Immunol 2021;12:658611. [PMID: 34012443 DOI: 10.3389/fimmu.2021.658611] [Reference Citation Analysis]
4 Gao LN, Li Q, Xie JQ, Yang WX, You CG. Immunological analysis and differential genes screening of venous thromboembolism. Hereditas 2021;158:2. [PMID: 33388092 DOI: 10.1186/s41065-020-00166-6] [Reference Citation Analysis]